Abstract CT231: Digital phenotyping in young breast cancer patients treated with neoadjuvant chemotherapy
Lidia Delrieu(Inserm), Fabien Reyal(Université Paris Sciences et Lettres), Florence Coussy(Inserm), Nicolas Forstmann(Netaji Subhas National Institute of Sports), Pauline Soibinet(Institut Jean Godinot), Élise Dumas(Inserm), Paul De Villèle(Issy Media (France)), Vincent Vercamer(Issy Media (France)), Armand Léopold(Institut Curie), Enora Laas(Institut Curie), Amyn Kassara(Inserm), Jean‐François Toussaint(Université Paris Cité), Adrien Sedeaud(Université Paris Cité), Julien Guérin(Institut Curie), Juliana Antero(Netaji Subhas National Institute of Sports), Christelle Jouannaud(Institut Jean Godinot), Bernard Asselain(UniCancer Group), Anne‐Sophie Hamy(Université Paris Cité), Maud Milder(Institut Curie), Judicaël Hotton(Institut Jean Godinot)
Cited by 0
Related Papers
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
|The Lancet Oncology|2017|1.1k
Improving health through policies that promote active travel: A review of evidence to support integrated health impact assessment
|Environment International|2011|620
Sports-Related Sudden Death in the General Population
|Circulation|2011|541
Psychological Balance in High Level Athletes: Gender-Based Differences and Sport-Specific Patterns
|PLoS ONE|2011|539
(untitled)
|Edinburgh Research Explorer|0|353